Company Filing History:
2 out of 1,217 
1 out of 83 
1 out of 3,566 
Years Active: 1997-2001
Title: Joseph DiPaolo: Innovator in Antisense Oligonucleotide Technology
Introduction
Joseph DiPaolo is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of antisense oligonucleotides for the treatment of human papilloma virus (HPV). With a total of 3 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
DiPaolo's latest patents focus on the inhibition of human papilloma virus through the use of antisense oligonucleotides. One of his patents discloses antisense oligonucleotides with a phosphorothioate backbone structure and sequences that are complementary to nucleotides contained within residues 415 to 445 of HPV-16. Additionally, he has developed methods of treatment utilizing these antisense oligonucleotides, which could provide new avenues for combating HPV infections.
Career Highlights
Throughout his career, Joseph DiPaolo has worked with esteemed organizations, including the United States of America as represented by the Department of Health and Northern Illinois University. His innovative research has positioned him as a key figure in the field of virology and molecular biology.
Collaborations
DiPaolo has collaborated with notable colleagues such as Luis Alvarez-Salas and Arnold E Hampel. These partnerships have likely contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Joseph DiPaolo's work in antisense oligonucleotide technology represents a significant advancement in the fight against human papilloma virus. His innovative patents and collaborations highlight his dedication to improving medical treatments and enhancing public health.